{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:58:01Z","timestamp":1791385081741,"version":"4.3.3"},"reference-count":39,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"4","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,7]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n                  <jats:p>\n                    Because of the global increase in resistance of\n                    <jats:italic>Campylobacter<\/jats:italic>\n                    to both fluoroquinolones and macrolides, we explored phenotypic resistance using traditional Kirby\u2013Bauer methods in human- and animal-derived\n                    <jats:italic>Campylobacter<\/jats:italic>\n                    isolates that were concurrently resistant to both azithromycin and ciprofloxacin to an expanded panel of antimicrobials, including clindamycin, fosfomycin, ampicillin and sulbactam, amoxicillin and clavulanic, fosfomycin, tigecycline, and imipenem. Of 235\n                    <jats:italic>Campylobacter<\/jats:italic>\n                    isolates resistant to ciprofloxacin and azithromycin, more than 94.8% of\n                    <jats:italic>Campylobacter jejuni<\/jats:italic>\n                    and\n                    <jats:italic>Campylobacter coli<\/jats:italic>\n                    were resistant to clindamycin, 68.5% were resistant to ampicillin and sulbactam, 2.6% were resistant to amoxicillin and clavulanic, and 36.2% were resistant to fosfomycin. Less than 2% of isolates were resistant to tigecycline, and there was no observed resistance to imipenem. The results suggest that amoxicillin and clavulanic warrant further evaluation for use in\n                    <jats:italic>Campylobacter<\/jats:italic>\n                    enteritis in ambulatory patients, but it points to no clear alternative oral therapies. Study findings were reassuring in demonstrating continued universal susceptibility to carbapenems.\n                  <\/jats:p>","DOI":"10.4269\/ajtmh.26-0268","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:08:38Z","timestamp":1785427718000},"page":"711-714","source":"Crossref","is-referenced-by-count":0,"title":["Phenotypic Resistance of Campylobacter Isolates to an Extended Panel of Antibiotics"],"prefix":"10.4269","volume":"115","author":[{"given":"Lucero","family":"Romaina Cachique","sequence":"first","affiliation":[{"name":"Asociacion Benefica PRISMA, Iquitos, Peru;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Schiaffino","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Medicine, Universidad Peruana Cayetano Heredia, San Martin de Porres, Lima, Peru;"},{"name":"Division of Infectious Diseases and International Health, School of Medicine, University of Virginia, Charlottesville, Virginia, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Paredes Olortegui","sequence":"additional","affiliation":[{"name":"Asociacion Benefica PRISMA, Iquitos, Peru;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Manzanares","sequence":"additional","affiliation":[{"name":"Asociacion Benefica PRISMA, Iquitos, Peru;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tackeshy","family":"Pinedo Vasquez","sequence":"additional","affiliation":[{"name":"Asociacion Benefica PRISMA, Iquitos, Peru;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Castro","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Medicine, Universidad Peruana Cayetano Heredia, San Martin de Porres, Lima, Peru;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana","family":"Najarro","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Medicine, Universidad Peruana Cayetano Heredia, San Martin de Porres, Lima, Peru;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry K.","family":"Cooper","sequence":"additional","affiliation":[{"name":"School of Animal and Comparative Biomedical Sciences, University of Arizona, Tucson, Arizona, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Mourkas","sequence":"additional","affiliation":[{"name":"Zoonosis Science Center, Department of Medical Sciences, Uppsala University, Uppsala, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Pascoe","sequence":"additional","affiliation":[{"name":"Ineos Oxford Institute for Antimicrobial Research, Department of Biology, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Pe\u00f1ataro Yori","sequence":"additional","affiliation":[{"name":"Asociacion Benefica PRISMA, Iquitos, Peru;"},{"name":"Division of Infectious Diseases and International Health, School of Medicine, University of Virginia, Charlottesville, Virginia, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig T.","family":"Parker","sequence":"additional","affiliation":[{"name":"School of Animal and Comparative Biomedical Sciences, University of Arizona, Tucson, Arizona, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret N.","family":"Kosek","sequence":"additional","affiliation":[{"name":"Asociacion Benefica PRISMA, Iquitos, Peru;"},{"name":"Division of Infectious Diseases and International Health, School of Medicine, University of Virginia, Charlottesville, Virginia, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"issue":"12","key":"b1","series-title":"Lancet Glob Health","first-page":"e1309","article-title":"Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: A reanalysis of the MAL-ED cohort study","volume":"6","author":"Platts-Mills","year":"2018"},{"issue":"6","key":"b2","series-title":"PLoS One","first-page":"e0158199","article-title":"Optimization of quantitative PCR methods for enteropathogen detection","volume":"11","author":"Liu","year":"2016"},{"issue":"12","key":"b3","series-title":"PLoS Med","first-page":"e1001921","article-title":"World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: A data synthesis","volume":"12","author":"Kirk","year":"2015"},{"issue":"14","key":"b4","series-title":"Emerg Infect Dis","first-page":"19","article-title":"Etiology and epidemiology of travelers\u2019 diarrhea among US military and adult travelers, 2018\u20132023","volume":"30","author":"Anderson","year":"2024"},{"issue":"11","key":"b5","series-title":"APMIS","first-page":"797","article-title":"Prevalence and characteristics of 11 potentially diarrhoeagenic microbes in asymptomatic individuals in Norway, 2015\u20132020","volume":"132","author":"Weme","year":"2024"},{"issue":"6","key":"b6","series-title":"Glob Health Med","first-page":"372","article-title":"Epidemiological trends of traveler\u2019s diarrhea in Japan: An analysis of imported infectious disease registry data from 2017\u20132022","volume":"5","author":"Maruki","year":"2023"},{"issue":"3","key":"b7","series-title":"MMWR Surveill Summ","first-page":"1","article-title":"Enteric disease outbreaks associated with animal contact\u2014Animal contact outbreak surveillance system, United States, 2009\u20132021","volume":"74","author":"Eisenstein","year":"2025"},{"issue":"4","key":"b8","series-title":"Emerg Infect Dis","first-page":"669","article-title":"Foodborne illness acquired in the United States\u2014Major pathogens, 2019","volume":"31","author":"Scallan Walter","year":"2025"},{"issue":"12","key":"b9","series-title":"Clin Infect Dis","first-page":"1963","article-title":"2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea","volume":"65","author":"Shane","year":"2017"},{"issue":"5","key":"b10","series-title":"Clin Infect Dis","first-page":"696","article-title":"A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species","volume":"44","author":"Ternhag","year":"2007"},{"key":"b11","series-title":"NARMS Now","year":"2025"},{"issue":"5","key":"b12","series-title":"Int J Antimicrob Agents","first-page":"107467","article-title":"Temporal, regional, and demographic differences among antimicrobial-resistant domestic Campylobacter jejuni human infections across the United States, 2013\u20132019","volume":"65","author":"Sodagari","year":"2025"},{"key":"b13","series-title":"BEAM (Bacteria, Enterics, Ameba, and Mycotics) Dashboard","year":"2026"},{"key":"b14","series-title":"Mil Med","first-page":"17","article-title":"Antibiotic therapy for acute watery diarrhea and dysentery","volume":"182","author":"Tribble","year":"2017"},{"issue":"5","key":"b15","series-title":"Antimicrob Agents Chemother","first-page":"e0168721","article-title":"Genomic screening of antimicrobial resistance markers in UK and US Campylobacter isolates highlights stability of resistance over an 18-year period","volume":"66","author":"van Vliet","year":"2022"},{"key":"b16","series-title":"J Glob Antimicrob Resist","first-page":"84","article-title":"Antimicrobial susceptibility testing and successful treatment of hospitalised patients with extensively drug-resistant Campylobacter jejuni infections linked to a pet store puppy outbreak","volume":"26","author":"Goyal","year":"2021"},{"key":"b17","series-title":"Scientifica (Cairo)","first-page":"7848926","article-title":"Virulence and antimicrobial resistance in Campylobacter spp. from a Peruvian pediatric cohort","volume":"2017","author":"Lluque","year":"2017"},{"key":"b18","series-title":"BMC Infect Dis","first-page":"193","article-title":"Campylobacter antimicrobial resistance in Peru: A ten-year observational study","volume":"12","author":"Pollett","year":"2012"},{"issue":"2","key":"b19","series-title":"Antimicrob Agents Chemother","first-page":"e01911","article-title":"Antibiotic resistance of Campylobacter species in a pediatric cohort study","volume":"63","author":"Schiaffino","year":"2019"},{"key":"b20","series-title":"J Glob Antimicrob Resist","first-page":"309","article-title":"Genomic resistant determinants of multidrug-resistant Campylobacter spp. isolates in Peru","volume":"36","author":"Schiaffino","year":"2024"},{"issue":"2","key":"b21","series-title":"mBio","first-page":"e0205424","article-title":"Sharing of cmeRABC alleles between C. coli and C. jejuni associated with extensive drug resistance in Campylobacter isolates from infants and poultry in the Peruvian Amazon","volume":"16","author":"Cooper","year":"2025"},{"issue":"1","key":"b22","series-title":"Emerg Infect Dis","first-page":"24","article-title":"Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: Resistance mechanisms and trends in human isolates","volume":"7","author":"Engberg","year":"2001"},{"issue":"3","key":"b23","series-title":"J Antimicrob Chemother","first-page":"596","article-title":"Global distribution, dissemination and overexpression of potent multidrug efflux pump RE-CmeABC in Campylobacter jejuni.","volume":"76","author":"Yao","year":"2021"},{"issue":"4","key":"b24","series-title":"Microbiol Spectr","first-page":"e0119723","article-title":"Cryo-electron microscopy structures of a Campylobacter multidrug efflux pump reveal a novel mechanism of drug recognition and resistance","volume":"11","author":"Zhang","year":"2023"},{"issue":"3","key":"b25","series-title":"Clin Microbiol Infect","first-page":"268","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012"},{"issue":"2","key":"b26","series-title":"PLoS Negl Trop Dis","first-page":"e0006200","article-title":"The other Campylobacters: Not innocent bystanders in endemic diarrhea and dysentery in children in low-income settings","volume":"12","author":"Fran\u00e7ois","year":"2018"},{"issue":"3","key":"b27","series-title":"PLoS Negl Trop Dis","first-page":"e0012018","article-title":"Novel rpsK\/rpsD primer-probe assay improves detection of Campylobacter jejuni and Campylobacter coli in human stool","volume":"18","author":"Schiaffino","year":"2024"},{"issue":"8","key":"b28","series-title":"Open Forum Infect Dis","first-page":"ofad378","article-title":"Epidemiology and antimicrobial resistance of Campylobacter infections in the United States, 2005\u20132018","volume":"10","author":"Ford","year":"2023"},{"issue":"2","key":"b29","series-title":"Antimicrob Agents Chemother","first-page":"542","article-title":"Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents","volume":"39","author":"Gomez-Garces","year":"1995"},{"issue":"8","key":"b30","series-title":"Emerg Infect Dis","first-page":"1708","article-title":"Case of extensively drug-resistant Shigella sonnei infection, United States","volume":"29","author":"Choi","year":"2023"},{"issue":"9","key":"b31","series-title":"Jpn J Antibiot","first-page":"1620","article-title":"Clinical trial of fosfomycin for Campylobacter enteritis.","volume":"37","author":"Nogawa","year":"1984"},{"issue":"11","key":"b32","series-title":"Eur J Clin Microbiol Infect Dis","first-page":"2101","article-title":"Antibiotic susceptibility profiles among Campylobacter isolates obtained from international travelers between 2007 and 2014","volume":"36","author":"Post","year":"2017"},{"issue":"1","key":"b33","series-title":"Trop Med Infect Dis","first-page":"25","article-title":"The global challenge of Campylobacter: Antimicrobial resistance and emerging intervention strategies","volume":"10","author":"Bukari","year":"2025"},{"issue":"5","key":"b34","series-title":"Antimicrob Agents Chemother","first-page":"813","article-title":"Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents","volume":"35","author":"Lachance","year":"1991"},{"issue":"7","key":"b35","series-title":"Clin Microbiol Infect","first-page":"928","article-title":"What is the evidence base of used aggregated antibiotic resistance percentages to change empirical antibiotic treatment? A scoping review","volume":"28","author":"Auzin","year":"2022"},{"issue":"7","key":"b36","series-title":"Ann Intern Med","first-page":"505","article-title":"Treatment of shigellosis: IV. Cefixime is ineffective in shigellosis in adults","volume":"123","author":"Salam","year":"1995"},{"key":"b37","series-title":"J Infect Dis","first-page":"S222","article-title":"Amoxicillin less effective than ampicillin against Shigella in\u00a0vitro and in\u00a0vivo: Relationship of efficacy to activity in serum","volume":"129","author":"Nelson","year":"1974"},{"issue":"7","key":"b38","series-title":"Antimicrob Agents Chemother","first-page":"4398","article-title":"Potential use of fosfomycin-tromethamine for treatment of recurrent Campylobacter species enteritis","volume":"60","author":"Aguilar-Company","year":"2016"},{"key":"b39","series-title":"J Microbiol Methods","first-page":"106649","article-title":"Comparison of disk diffusion and broth microdilution methods for antimicrobial susceptibility testing of Campylobacter isolates of meat origin","volume":"204","author":"Lazou","year":"2023"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/115\/4\/article-p711.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/115\/4\/article-p711.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/115\/4\/article-p711.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:24:25Z","timestamp":1791383065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/115\/4\/article-p711.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":39,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.26-0268","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]}}}